Page 165 - Genentech News Today

CARLSBAD Annual street fair takes place Sunday The Carlsbad Chamber of Commerce invites all to the annual Carlsbad Village Street Faire from 8 a.m. to 5 p.m. today in downtown Carlsbad.

New study suggests off-label treatment with Roche's Avastin could be as effective as using Novartis' eye drug

DESTIN, Fla. — Stratifying Sjögren’s disease patients by symptoms or biologic parameters may help rheumatologists hit therapeutic targets, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

Treatment intensification with darolutamide plus androgen deprivation therapy and docetaxel improved OS among men with metastatic hormone-sensitive prostate cancer regardless of disease volume or risk, according to study results.The benefits of early treatment intensification appeared consistent among men with high-volume or low-volume disease, as well as those with high-risk or low-risk disease,

–Multiple vepdegestrant studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib... | May 5, 2023

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

The 2022-2023 COVID-19 season did not have a significant surge of COVID-19 like it did early on in the COVID-19 pandemic.

DESTIN, Fla. — Despite advances in biologic therapies, “excess steroid use” remains a mainstay of treatment for patients with ANCA-associated vasculitis,” according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

Pollen storms, air pollution, flooding, and other phenomena related to climate change are taxing pulmonary care specialists as never before.

The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are miniature